HomeCompareGECFF vs JNJ

GECFF vs JNJ: Dividend Comparison 2026

GECFF yields 8.27% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GECFF wins by $7.0K in total portfolio value
10 years
GECFF
GECFF
● Live price
8.27%
Share price
$77.83
Annual div
$6.44
5Y div CAGR
-12.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.0K
Annual income
$302.38
Full GECFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GECFF vs JNJ

📍 GECFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGECFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GECFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GECFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GECFF
Annual income on $10K today (after 15% tax)
$702.89/yr
After 10yr DRIP, annual income (after tax)
$257.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $446.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GECFF + JNJ for your $10,000?

GECFF: 50%JNJ: 50%
100% JNJ50/50100% GECFF
Portfolio after 10yr
$23.5K
Annual income
$565.08/yr
Blended yield
2.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GECFF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.6
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GECFF buys
0
JNJ buys
0
No recent congressional trades found for GECFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGECFFJNJ
Forward yield8.27%3.36%
Annual dividend / share$6.44$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-12.3%5.8%
Portfolio after 10y$27.0K$20.0K
Annual income after 10y$302.38$827.78
Total dividends collected$5.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: GECFF vs JNJ ($10,000, DRIP)

YearGECFF PortfolioGECFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,425$725.22$10,676$355.77+$749.00GECFF
2$12,904$679.12$11,407$389.39+$1.5KGECFF
3$14,436$628.68$12,198$426.53+$2.2KGECFF
4$16,023$576.45$13,056$467.62+$3.0KGECFF
5$17,669$524.42$13,987$513.12+$3.7KGECFF
6$19,380$473.98$14,998$563.56+$4.4KGECFF
7$21,163$426.10$16,098$619.52+$5.1KGECFF
8$23,025$381.37$17,295$681.69+$5.7KGECFF
9$24,977$340.10$18,599$750.82+$6.4KGECFF
10$27,028$302.38$20,022$827.78+$7.0KGECFF

GECFF vs JNJ: Complete Analysis 2026

GECFFStock

Gecina operates innovative and sustainable living spaces. The Group owns, manages and develops Europe's leading office portfolio, with nearly 97% located in the Paris Region, and a portfolio of residential assets and student residences, with over 9,000 apartments. These portfolios are valued at 20 billion euros at end-June 2020. Gecina has firmly established its focus on innovation and its human approach at the heart of its strategy to create value and deliver on its purpose: "Empowering shared human experiences at the heart of our sustainable spaces". For our 100,000 clients, this ambition is supported by our client-centric brand YouFirst. It is also positioned at the heart of UtilesEnsemble, our label setting out our commitment to the environment, to people and to the quality of life in cities. Gecina is a French real estate investment trust (SIIC) listed on Euronext Paris, and is part of the SBF 120, CAC Next 20, CAC Large 60, Euronext 100, FTSE4Good, DJSI Europe and World, Stoxx Global ESG Leaders and Vigeo indices. In 2020, Gecina was awarded the maximum A rating in the CDP climate change rankings.

Full GECFF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GECFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GECFF vs SCHDGECFF vs JEPIGECFF vs OGECFF vs KOGECFF vs MAINGECFF vs ABBVGECFF vs MRKGECFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.